Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alcoholism
Research reports on alcoholism from University of Lisbon, Institute of Molecular Medicine provide new insights
April 20th, 2008
Current study results from the report, 'Elevated nitric oxide and 3',5' cyclic guanosine monophosphate levels in patients with alcoholic cirrhosis,' have been published. In this recent study, researchers in Lisboa, Portugal conducted a study "To evaluate whether serum levels of nitric oxide (NO*) and plasma levels of cyclic guanosine monophosphate (cGMP) and total glutathione (GSH) are altered in patients with alcoholic cirrhosis and to examine their correlation with the severity of liver disease. Twenty-six patients with alcoholic liver cirrhosis were studied." "Serum levels of NO* and plasma levels of cGMP and GSH were measured in 7 patients with compensated alcoholic...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-20)
|
